Glox Therapeutics has received a portion of a £3 million fund to combat antimicrobial resistance in cystic fibrosis patients. The CF AMR Syndicate, which combines expertise from various sectors ...

New cell therapy, Cilta-cel, shows promise in the treatment of multiple myeloma, providing a personalised approach with the ...

Rigel Pharmaceuticals has announced the enrolment of the first patient in a Phase I trial evaluating fostamatinib for sickle cell disease. Fostamatinib, marketed as TAVALISSE ® in the US for chronic ...

Cancer Research UK, Cytovation, and the Norwegian Cancer Society have teamed up to advance the treatment of adrenocortical carcinoma (ACC). The collaboration will support the Phase II clinical trial ...

Learn about the gut-brain connection in mental health and how targeting serotonin in the gut could revolutionise ...

New study reveals that TLE6 protein deficiency causes male infertility in mice. These findings suggest potential genetic causes and future treatment avenues for male infertility. Genetic changes are a ...

Explore how FDA’s Project Optimus is reshaping oncology drug dosing strategies, with insights on precision medicine, adaptive trial designs, and the role of CROs in optimising patient outcomes.

Cookie Type Duration Description bcookie persistent 2 years This cookie is set by LinkedIn. The purpose of the cookie is to enable LinkedIn functionalities on the page. GPS persistent 30 minutes This ...

UVA researchers found that continuous glucose monitor data can predict nerve, eye, and kidney damage in type 1 diabetes. Researchers at the University of Virginia Center for Diabetes Technology have ...